THE EFFECTIVENESS OF PROVISIONAL STENTING STRATEGY FOR FEMOROPOPLITEAL ARTERY INTERVENTIONS IN ALL-COMER POPULATIONS  by nagashima, yoshinori et al.
TCT@ACC-i2: The Interventional Learning Pathway
A1830
JACC April 1, 2014
Volume 63, Issue 12
the effectiVeness of ProVisionAl stenting strAtegy for feMoroPoPliteAl Artery 
interVentions in All-coMer PoPulAtions
Poster Contributions
Hall C
Sunday, March 30, 2014, 9:45 a.m.-10:30 a.m.
Session Title: Carotid and Endovascular Intervention
Abstract Category: 37. TCT@ACC-i2: Carotid and Endovascular Intervention
Presentation Number: 2106-307
Authors: Yoshinori Nagashima, Masanori Shiba, Masato Nakamura, Kaoru Sugi, Toho University Ohashi Medical Center Division of Cardiovascular 
Medicine, Tokyo, Japan
background: Drug-eluting stent (DES) with femoropopliteal lesions have improved patency results. However, long lesions were excluded from 
current study. The treatment of in-stent-restenosis in the femoropopliteal artery is still unsolved problem. Furthermore, there was no significant 
difference in patency for primary DES compared with provisional DES placement through follow up period. The purpose of this study was to 
investigate the effectiveness strategy of provisional stenting for femoropopliteal artery lesions in all-comer populations.
Methods: This study was a single center, retrospective analysis. From January 2011 to March 2013, 133 consecutive limbs (90 patients) underwent 
percutaneous transluminal angioplasty (PTA) of provisional stenting strategy for the treatment of femoropopliteal artery lesions. Primary endpoint 
was freedom from Major adverse limb events (MALE; any cause of death, Target lesion revascularization (TLR), above-ankle amputation of the index 
limb). Secondary endpoint was freedom from TLR between TASC A+B and TASC C+D.
results: Mean age was 71±9 years. Proportions of patient characteristics were male (71.1%), hypertensive (93.2%), Diabetes mellitus (71.2%), 
hemodialysis (46%). The rate of TASC A, B, C and D were 21.8%, 16.5%, 36.8%, and 23.3%, respectively. Procedural success rate was 97.7%. The rate 
of provisional stenting and optimal PTA were 39.8% and 60.2%. The rate of DES was 10.5%. There was no significant difference between provisional 
stent group and optimal PTA group about Freedom from MALE in all patients (P=0.73, 62.7% vs. 64.7%, median=368.0days). There was significant 
difference about freedom from MALE between TASC A+B and TASC C+D in optimal PTA group (P=0.03, 68.2% vs. 56.0%). However, there was no 
significant difference about freedom from MALE between TASC A+B and TASC C+D in provisional stenting group (P=0.82, 59.4% vs. 57.3%). Over 
150mm lesion length was only contribute factor about TLR in this treatment strategy (P=0.045).
conclusions: In all-comer population patients with femoropopliteal artery lesions, provisional stenting strategy result a favorable acute, midterm 
outcome without any complications.
